Line” rating to Kimberly-Clark Corporation (KMB), suggesting that while the stock is fairly valued at its current price of $100.64, there appears to be upside potential toward the $120 price target.

Knife River Corporation (KNF) has recently caught the eye of investors as Wells Fargo’s Timna Tanners upgraded the stock to an Overweight rating o. This designation, accompanied by a price target of ...

Dow Jones Top Financial Services Headlines at 4 PM ET: Apollo Invests $75 Billion in Quarter As Firm Continues to Grow Deal Capacity | Sequoia ... Apollo Invests $75 Billion in Quarter As Firm ...

The Kimberly-Clark/Kenvue transaction is one of the worst-received major merger deals in recent years. Investors wondered why ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...

Dow Jones Top Financial Services Headlines at 11 AM ET: Bank of America's First Investor Day Since 2011 Is Coming. Why the CEO Is on the Hot Seat. | Financial ... Bank of America's First Investor Day ...

A number of prominent hedge funds are likely applauding Monday’s news that Kimberly-Clark Corp. has agreed to acquire Kenvue ...

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears ...

Kimberly-Clark plans to acquire Kenvue in a $48.7 billion deal, aiming to boost long-term growth and synergies. Learn more ...

Despite a headline beat and decent revenue forecast, the poor reaction to the update from AI and data analytics darling ...